Back to search
Heart Failure - NYHA II - IV
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure - NYHA II - IV trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Heart Failure - NYHA II - IV trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
This study is open to adults with chronic heart failure (HF) who have a reduced left ventricular ejection fraction (LVEF) of less than 40%. People can join the…
This study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular…
This study will compare two different methods to pace the heart to treat heart failure including: 1. The current standard method of implanting a pacing lead in…
This prospective, single-center and observational study aims to develop and validate the single-feature artificial intelligence algorithm based on data collecte…
Heart Failure (HF) is a complex disease associated with the highest burden of cost to the healthcare system. The cardiopulmonary exercise test (CPET) is instrum…
PEDAL-HF is a registry-based randomized prospective multicenter study. The investigators plan to include 1000 patients who were recently admitted with acute dec…
The goal of this clinical trial is to learn whether mitral valve transcatheter edge-to-edge repair (TEER) in addition to guideline-directed medical therapy (GDM…
The primary objective of this study is to monitor the safety profile of Jardiance® in Korean patient with chronic heart failure (New York Heart Association (NYH…